Our study on the in vivo heterozygous knockout of KIF5B in the P301S mouse model of tauopathy showed that a 50% drop in the KIF5B level was sufficient to reduce overall tau levels and rescue the phenotype. The gene discussed is MAPT; the disease is tauopathy.